Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

5.40
Delayed Data
As of Oct 20
 -0.23 / -4.09%
Today’s Change
4.94
Today|||52-Week Range
7.88
+0.93%
Year-to-Date
No recent news for ZIOPHARM Oncology Inc.

Today’s Trading

Previous close5.63
Today’s open5.65
Day’s range5.39 - 5.65
Volume1,179,230
Average volume (3 months)1,078,501
Market cap$766.6M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)+57.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.38%
P/E ratioNM
Price/Sales101.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.55+3.68%
BYSIBeyondspring Inc-6.01-17.17%
ATNXAthenex Inc+0.05+0.29%
ACORAcorda Therapeutics ...+0.50+1.87%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$6.9M
Annual profit (last year)-$165.3M
Net profit margin-2,409.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts